EUVIMEDEUVIMED entdecken
Studienprotokoll

Rifampicin does not reduce moxifloxacin concentrations at the site of infection and may not improve treatment outcome of a one‐stage exchange surgery protocol of implant‐associated osteomyelitis lesions in a porcine model

Sofus Vittrup iD, Louise Kruse Jensen, Katrine Top Hartmann, Bent Aalbaek, Pelle Hanberg, Josefine Slater, Magnus Andreas Hvistendahl, Maiken Stilling, Nis Pedersen Jørgensen, Mats Bue

APMIS · 2024

DOI: 10.1111/apm.13371 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift APMIS, 2024. Verfasst von Sofus Vittrup und 9 weiteren Autor:innen. Beteiligte Einrichtung: Aarhus Denmark Microdialysis Research (ADMIRE), Orthopaedic Research Laboratory, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Osteomyelitis, Rifampin. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: A.P. Møller og Hustru Chastine Mc-Kinney Møllers Fond til almene Formaal, Aarhus Universitets Forskningsfond, Direktør Emil C. Hertz og Hustru Inger Hertz Fond.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We aimed to evaluate moxifloxacin steady‐state concentrations in infected bone and soft tissue and to explore the additive microbiological and pathological treatment effect of rifampicin to standard moxifloxacin treatment of implant‐associated osteomyelitis (IAO). 16 pigs were included. On Day 0, IAO was induced in the proximal tibia using a susceptible Staphylococcus aureus strain. On Day 7, the pigs underwent one‐stage exchange surgery of the IAO lesions and were randomized to receive seven days of intravenous antibiotic treatment of either rifampicin combined with moxifloxacin or moxifloxacin monotherapy. On Day 14, microdialysis was applied for continuous sampling (8 h) of moxifloxacin concentrations. Microbiological, macroscopical pathology, and histopathological analyses were performed postmortem. Steady‐state moxifloxacin area under the concentration–time curve was lower in the combination therapy group in plasma (total) and subcutaneous tissue compartments (infected and noninfected) (p < 0.04), while no differences were found in bone compartments. No additional treatment effect of rifampicin to moxifloxacin treatment was found (p = 0.57). Conclusive, additive rifampicin treatment does not reduce moxifloxacin concentrations at the infection site. Rifampicin treatment may not be necessary in a one‐stage exchange treatment of IAO. However, our sample size and treatment period may have been too small and short to reveal true clinical differences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteomyelitisRifampinAnimalsAnti-Bacterial AgentsFluoroquinolonesMoxifloxacinSwineTreatment Outcome

Stichwörter der Autor:innen

Implant-associated osteomyelitismicrodialysismoxifloxacinone-stage exchangerifampicin

Substanzen

Anti-Bacterial AgentsFluoroquinolonesMoxifloxacinRifampin

Autor:innen und Institutionen

  • Aarhus Denmark Microdialysis Research (ADMIRE), Orthopaedic Research Laboratory, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark.
  • Department of Orthopaedic Surgery, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.

ORCID-Profile: Sofus Vittrup

Förderung

  • A.P. Møller og Hustru Chastine Mc-Kinney Møllers Fond til almene Formaal
  • Aarhus Universitets Forskningsfond
  • Direktør Emil C. Hertz og Hustru Inger Hertz Fond
  • Frimodt-Heineke Fonden
  • Gigtforeningen
  • Grosserer A.V. Lykfeldt og Hustrus Legat
  • Kai Lange og Gunhild Kai Langes Fond
  • Oda og Hans Svenningsens Fond

Zitieren

APA

Vittrup, S., Jensen, L. K., Hartmann, K. T., Aalbaek, B., Hanberg, P., Slater, J., Hvistendahl, M. A., Stilling, M., Jørgensen, N. P., & Bue, M. (2024). Rifampicin does not reduce moxifloxacin concentrations at the site of infection and may not improve treatment outcome of a one‐stage exchange surgery protocol of implant‐associated osteomyelitis lesions in a porcine model. APMIS. https://doi.org/10.1111/apm.13371

Vancouver

Vittrup S, Jensen LK, Hartmann KT, Aalbaek B, Hanberg P, Slater J, et al. Rifampicin does not reduce moxifloxacin concentrations at the site of infection and may not improve treatment outcome of a one‐stage exchange surgery protocol of implant‐associated osteomyelitis lesions in a porcine model. APMIS. 2024. doi:10.1111/apm.13371

BibTeX
@article{Vittrup2024,
  author = {Vittrup, Sofus and Jensen, Louise Kruse and Hartmann, Katrine Top and Aalbaek, Bent and Hanberg, Pelle and Slater, Josefine and Hvistendahl, Magnus Andreas and Stilling, Maiken and Jørgensen, Nis Pedersen and Bue, Mats},
  title = {Rifampicin does not reduce moxifloxacin concentrations at the site of infection and may not improve treatment outcome of a one‐stage exchange surgery protocol of implant‐associated osteomyelitis lesions in a porcine model},
  journal = {APMIS},
  year = {2024},
  doi = {10.1111/apm.13371}
}
Kostenlos starten →